MERS Coronavirus: The US Response David L. Swerdlow, MD CAPT, USPHS Incident Manager, CDC MERS Coronavirus Response Associate Director for Science National.

Slides:



Advertisements
Similar presentations
MERS-CoV: the global epidemiology
Advertisements

MERS-CoV: example of hospital cluster Republic of Lebanon Ministry of Public Health Epidemiological Surveillance Program May 2014.
Middle East Respiratory Syndrome (Coronavirus) Middle East Respiratory Syndrome (MERS) is viral respiratory illness first reported in Saudi Arabia in 2012.
MERS: Middle East Respiratory Syndrome Overview & The Role of Public Health Christine Wigen, MD, MPH Medical Epidemiologist, Acute Communicable Disease.
How can Modeling Help in Emerging Epidemics? John Grefenstette, PhD Public Health Dynamics Lab Health Policy & Management Pitt Public Health Dec 5, 2014.
Introduction of Surveillance and Prevention of H1N1 Flu in Yunnan Department of Public Health of Yunnan Province Speaker : Hu Shou Jing Report Time : Fifteen.
Reportable Disease Update Local Health Department Nurses Meeting June 20, 2013 T.J. Sugg, MPH.
Middle East Respiratory Syndrome (MERS) By : Javad sheykhzadeh M.D Student of MPH Tehran university of medical sciences.
Screening of Human and Animal Sera from Egypt and Hong Kong Perera et al. Euro Surveill. 2013;18(36):pii=20574 Sampled 1343 Human, 625 animals.
INFLUENZA A (H1N1) SWINE FLU : EVOLUTION OF THE PROBLEM BY DR ESSAM EL-GAMAL Professor of Chest Diseases Mansoura Faculty of Medicine Tuesday May, 5, 2009.
Public Health Interventions: lessons learned Mark Loeb MD, MSc McMaster University.
1 Health Alerts David Trump, MD, MPH, MPA Acting Chief Deputy Commissioner for Public Health and Preparedness & State Epidemiologist Health and Medical.
World Health Organization, 15 June 2003
Challenges of the 2009 H1N1 Pandemic Influenza: Charles Penn Global Influenza Programme World Health Organization Geneva.
 Refers to an illness caused by any of many different strains of influenza viruses that have adapted to a specific host.  It considers as a flu.  You.
Modeling Lessons Learned from the SARS Outbreak Paul A. Dreyer Jr., Ph.D. Associate Mathematician RAND.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
SARS Timeline Nov 16 ‘02 Feb 11 ‘03 Feb 28 March 11 March 12 March 19 March 27 April 5 April 9 April 14 April 17 April 28 First cases Hong Kong WHO Sequence.
SARS Timeline Nov 16 ‘02 Feb 11 ‘03 Feb 28 March 11 March 12 March 19 March 27 April 5 April 9 April 14 April 17 April 28 First cases Hong Kong WHO Sequence.
SARS Epidemic: A Global Challenge Bong-Min Yang, PhD & Sung-il Cho, MD, PhD of School of Public Health Seoul National University.
Modeling the SARS epidemic in Hong Kong Dr. Liu Hongjie, Prof. Wong Tze Wai Department of Community & Family Medicine The Chinese University of Hong Kong.
Middle East Respiratory Syndrome (MERS-CoV)
Severe Acute Respiratory Syndrome Up-To-Date Details as of March 26.
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
Epidemic Vs Pandemic 8.L.1.2.
Human Infection with Avian Influenza A(H7N9) Virus: Situation and Response, China Zijian FENG Center for Public Health Emergency Center Chinese Center.
Novel Coronavirus and H7N9 Influenza Infections Situation update May 2013 Craig Roberts, PA-C, MS ACHA Emerging Public Health Threats & Emergency Response.
Severe Acute Respiratory Syndrome (SARS) Michael Leonard.
Response to pandemic (H1N1) Country experience - Japan Tomimasa Sunagawa Infectious Disease Surveillance Center National Institute.
Emerging Infections of Concern Health and Human Resources Subpanel Governor’s Secure Commonwealth Initiative March 2015.
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Update April 29, 2014.
Epidemiology of invasive meningococcal disease in the Netherlands and impact of serogroup C vaccination National surveillance data (Netherlands Reference.
Learning Goals Appreciate that events on the other side of the world affect us.
Responding to SARS John Watson Health Protection Agency Communicable Disease Surveillance Centre, London.
Public Health Issues of Interest Seasonal Influenza Seasonal Norovirus Middle East Respiratory Syndrome Coronavirus Novel Influenza (A/H7N9) David H. Trump,
SEARO –CSR Early Warning and Surveillance System Module Case Definitions.
Danilo Saniatan R.N Charge Nurse RAC-Khurais Clinic.
Emerging Infectious Diseases: SARS and Avian Influenza Sonja J. Olsen, PhD International Emerging Infections Program Thailand Ministry of Public Health.
Papua New Guinea Update 3 rd NIC Meeting 18 – 20 Beijing, China Berry Ropa National CSR Officer Department of Health Papua New Guinea.
Preparing for a Influenza Pandemic in Utah Robert T. Rolfs, MD, MPH Utah Department of Health December 4, 2006.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
US Situation Update and CDC International Response H1N1 Pandemic US Situation Update and CDC International Response Peter Nsubuga, MD, MPH On behalf of.
SARS. What is SARS? Severe Acute Respiratory Syndrome Respiratory illness Asia, North America, and Europe Previously unrecognized coronavirus.
Jeremy Buige 2B.
SEVERE ACUTE RESPIRATORY SYNDROME – UPDATE Anne-Claire de Benoist and Delia Boccia, European Programme for Intervention.
Severe Acute Respiratory Syndrome (SARS) Introduction.
Communicable Disease Surveillance and Response, WHO Avian Influenza Credit: WHO Viet Nam.
Epidemiology and Surveillance: Lessons from Past Pandemics Arnold S. Monto, MD Professor of Epidemiology University of Michigan School of Public Health.
Epidemiology of Severe Acute Respiratory Syndrome (SARS)
Emerging Diseases Lecture 9: Filoviruses 9.1 Overview 9.2: Outbreaks: Marburg, N’zara, Yambuku, Reston, Kikwit, West Africa 9.3 Summary.
Vaccines and Related Biological Products Advisory Committee Meeting July 23, 2009 Novel influenza A (H1N1) Epidemiology Update Anthony Fiore, MD, MPH Influenza.
Health Security and Emergencies MERS Coronavirus (as of 3 Jun 2015) Ariuntuya, TO, ESR, WHO, Mongolia.
MERS Middle East Respiratory Syndrome. FACTS The Middle East Respiratory Syndrome (MERS) is a viral respiratory disease caused by a novel coronavirus.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
MERS-CoV: example of family cluster Republic of Lebanon Ministry of Public Health Epidemiological Surveillance Program May 2014.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Current Pandemic H1N1 Updates in the Philippines Department of Health, Philippines Juan M. Lopez, MD, PGradDipPH, MPH Aldrin Q. Reyes, RN.
Discuss the impact of one ID on the health, econ development and lifestyle of the area(s) where it occurs.
MERS-CoV (Middle Eastern Respiratory Syndrome) Mike Wade – 16/06/15, updated 23/7/15.
SARS Severe Acute Respiratory Syndrome Jeffrey S. Duchin, M.D. Chief, Communicable Disease Control, Epidemiology and Immunization Section, Public Health.
مقدمه کوروناویروس ها ویروس های بزرگی هستند که باعث بيماري هاي متنوعي در بسياري از حيوانات مي شوند و درگذشته به عنوان عامل سرماخوردگی انسان شناخته.
Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility  Simon Cauchemez,
Laboratory research in camel diseases, UAE: update on MERS-CoV
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
World Health Organization
Reported Lyme Disease Cases by Year United States, ,000 10,000 15,000 20,000 25,
Reusable maps and graphs from ECDC Communicable Disease Threats Report Week 10, 2019 You are encouraged to reuse our maps and graphs for your own purposes.
Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility  Simon Cauchemez,
Corona Virus Infection
Electrification business
Presentation transcript:

MERS Coronavirus: The US Response David L. Swerdlow, MD CAPT, USPHS Incident Manager, CDC MERS Coronavirus Response Associate Director for Science National Center for Immunization and Respiratory Diseases November 6, 2013

MERS Coronaviruses (MERS CoV) Outline Lessons from SARS Emergence and epidemiology of MERS The US response- domestic and global

SARS Epidemic Occurred ,098 probable cases, 774 deaths Estimated economic losses >$30B Super-spreading events helped seed global spread - E.g., traveler at Hong Kong hotel spread virus to several countries Control strategies: - Surveillance to identify cases - Isolation of ill - Quarantine of exposed - Good infection control

MERS Coronavirus- current situation as of October 29, 2013 First case reported from KSA in September 2012 Outbreak in Jordan April 2012 identified retrospectively 150 laboratory confirmed cases with 64 (43%) deaths* Gender: 91 Males (63%), 53 Females [6 Unknown] Median age (min, max) in years: 52 (2, 94) Most with underlying conditions 24 (16%) of 150 cases health care workers

MERS CoV Cases and Deaths Confirmed by WHO CountriesCases (Deaths) Saudi Arabia125 (53) Qatar7 (3) United Arab Emirates6 (2) Tunisia3 (1) United Kingdom3 (2) France2 (1) Jordan2 (2) Italy1 (0) Total 150 (64)

Cases or clusters associated with returning travelers United Kingdom: 2/13- 3 cases, 2 deaths- Retuning traveler from KSA and family France: 4/ yo French traveler returning from UAE and 51 yo hospital roommate Tunisia: 5/13- Returning traveler from Qatar (died) and two adult children Italy: 5/13- Returning traveler from Jordan. Ill niece and co-worker were probable cases

Possible Environmental (Animal) Source Bats: PCR testing – Similar virus--Ghana and Europe 1 ; South Africa 2 – Identical small DNA fragment in bat sampled near first case in KSA 3 Camels: Serology – Camels from Oman (100%) and Spain (14%) had antibodies to MERS, other animals neg 4 – Camels from Egypt (94-98%), other humans and animals in Egypt and China neg 5 No direct evidence available 1 Annan A, et al. Emerg Infect Dis 2013;19:456-59; 2 Ithete NL, et al. EID 2013;10 epub; 3 Memish Z, et al, EID Ahead of Print, 8/21/13; 4 Reusken CBEM, et al. Lancet ID 2013;18:860-6; 5 Perera RA et al. Eurosurveillance 2013;18 (36) pii 20574